JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 11, 2006; DOI: 10.1124/jpet.106.101915


0022-3565/06/3181-108-116$20.00
JPET 318:108-116, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Erratum
Right arrow An erratum has been published
Right arrow All Versions of this Article:
jpet.106.101915v1
318/1/108    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cengelli, F.
Right arrow Articles by Juillerat-Jeanneret, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cengelli, F.
Right arrow Articles by Juillerat-Jeanneret, L.

NEUROPHARMACOLOGY

Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures

Feride Cengelli, Dusica Maysinger, Florianne Tschudi-Monnet, Xavier Montet, Claire Corot, Alke Petri-Fink, Heinrich Hofmann, and Lucienne Juillerat-Jeanneret

University Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (F.C., L.J.-J.); Department of Pharmacology, McGill University, Montreal, Canada (D.M.); Institute of Physiology, University of Lausanne, Lausanne, Switzerland (F.T.-M.); Department of Cell Physiology and Metabolism and Medical Radiology, University of Geneva, Geneva, Switzerland (X.M.); Guerbet Research, Roissy, France (C.C.); and Institute of Materials Science, Laboratory of Powder Technology, Swiss Federal Institute of Technology (Ecole Polytechnique Fédérale de Lausanne), Lausanne, Switzerland (A.P.-F., H.H.)

Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) combined with magnetic resonance imaging (MRI) are under clinical evaluation to enhance detection of neurodegenerative diseases. A major improvement would be to link therapeutic drugs to the SPIONs to achieve targeted drug delivery, either at the cell surface or intracellularly, together with active disease detection, without inducing cell reaction. Our objectives were to define the characteristics of SPIONS able to achieve cell-specific interaction with brain-derived structures. Our system consisted in an iron oxide core (9-10 nm diameter) coated either with dextran (Sinerem and Endorem) or various functionalized polyvinyl alcohols (PVAs) (PVA-SPIONs). We investigated the cellular uptake, cytotoxicity, and interaction of these various nanoparticles with brain-derived endothelial cells, microglial cells, and differentiating three-dimensional aggregates. None of the nanoparticles coated with dextran or the various PVAs was cytotoxic or induced the production of the inflammatory mediator NO used as a reporter for cell activation. AminoPVA-SPIONs were taken up by isolated brain-derived endothelial and microglial cells at a much higher level than the other SPIONs, and no inflammatory activation of these cells was observed. AminoPVA-SPIONs did not invade brain cells aggregates lower than the first cell layer and did not induce inflammatory reaction in the aggregates. Fluorescent aminoPVA-SPIONs derivatized with a fluorescent reporter molecule and confocal microscopy demonstrated intracellular uptake by microglial cells. Fluorescent aminoPVA-SPIONs were well tolerated by mice. Therefore, functionalized aminoPVA-SPIONs represent biocompatible potential vector systems for drug delivery to the brain that may be combined with MRI detection of active lesions in neurodegenerative diseases.


Received January 26, 2006; accepted April 10, 2006.

Address correspondence to: Dr. Lucienne Juillerat, University Institute of Pathology, Bugnon 25, CH-1011 Lausanne, Switzerland. E-mail: lucienne.juillerat{at}chuv.ch







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.